ChronoScale Holdings Corporation CHRN
19.85
(2.00)
(9.15%)
as of 25 Sep
- Market cap
- $3.1B
- P/E
- 0.0×
Follow CHRN
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | May '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | — |
P/S ratio |
0.16 | 0.25 | 3.28 | — | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | — | |
P/Operating CF |
(54.11) | (4.84) | (17.87) | — | |
P/B ratio |
1.39 | 2.32 | 18.16 | — | |
Price to Tangible BV |
2.63 | 4.11 | 0.00 | — | |
EV/Sales |
0.16 | 0.27 | 3.16 | — | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | — | |
EV/Operating CF |
(1.26) | (1.70) | (3.60) | — | |
EV/FCF |
(1.24) | (1.67) | (3.53) | — | |
Quick Ratio |
0.98 | 0.98 | 0.94 | — | |
Current Ratio |
1.66 | 1.63 | 1.55 | — | |
Net Debt/EBITDA |
(0.28) | (0.40) | 0.27 | — | |
Debt/Assets |
13.88% | 13.95% | 13.19% | 0.00% | |
Debt/Equity |
0.31 | 0.31 | 0.45 | — | |
Asset Turnover |
3.49 | 3.55 | 1.18 | 0.00 | |
Operating CF/Net income |
0.17 | 0.93 | 0.31 | — | |
Capex/Depreciation |
(0.02) | (0.28) | 0.00 | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | — | |
Research and Development Expense of Revenue |
13.01% | 20.41% | 27.23% | — | |
Selling, General and Administrative Expense of Revenue |
80.46% | 176.40% | 285.33% | — | |
Intangible Assets out of Total Assets |
0.21 | 0.20 | 0.20 | 0.00 | |
Share Based Compensation of Revenue |
50.96% | 24.94% | 5.32% | — | |
Graham Net Nets |
0.21 | 0.14 | 0.00 | — | |
Graham Number |
0.00 | 0.00 | 0.00 | — | |
Earnings Yield |
(11.93%) | (4.31%) | (50.52%) | — | |
Free Cash Flow Yield |
(82.09%) | (64.40%) | (27.31%) | — | |
Revenue per Share |
1.62 | 1.29 | 0.60 | — | |
Operating CF per Share |
(0.09) | (1.79) | (0.60) | — | |
Capex per Share |
0.50 | (0.05) | 0.00 | — | |
Free Cash Flow per Share |
0.41 | (1.84) | (0.60) | — | |
Cash per Share |
1.04 | 0.48 | 1.12 | — | |
Shareholders Equity per Share |
3.70 | 3.72 | 1.61 | — | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | — | |
Book value per Share |
3.70 | 3.72 | 1.61 | — | |
Free Cash Flow |
1.07 | (4.46) | (2.12) | — | |
Working Capital |
5.86 | 5.41 | 4.96 | — | |
Capital Expenditures |
1.31 | (0.13) | — | — | |
Net Current Asset Value |
2.81 | 2.97 | 0.13 | — | |
EV/EBIT |
0.00 | 0.00 | 0.00 | — | |
Capex to Sales |
(0.31) | 0.04 | 0.00 | — | |
Net Profit Margin |
(33.62%) | (148.85%) | (321.58%) | — | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | — | |
| Other line items | |||||
Average Receivables |
6.51 | 7.27 | 5.50 | — | |
Average Payables |
1.73 | 1.49 | 2.05 | — | |
Average Inventory |
5.03 | 4.70 | 4.81 | — | |
Average Assets |
24.16 | 23.71 | 9.83 | 11.58 | |
Average Common Equity |
12.27 | 10.87 | 7.39 | — |
Columns are period end dates